S R Damle1, R K Martin1, C L Cockburn1, J C Lownik2, J A Carlyon1, A D Smith3, D H Conrad1. 1. Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA, USA. 2. Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond, VA, USA. 3. United States Department of Agriculture, Diet, Genomics, and Immunology Laboratory, Agricultural Research Service, Beltsville Human Nutrition Research Center, Beltsville, MD, USA.
Abstract
BACKGROUND: Allergy and allergic asthma are significant health burdens in developed countries and are increasing in prevalence. Dendritic cells (DCs) initiate immune responses to common aeroallergens, and ADAM10 has been demonstrated to be important for the development of adaptive responses. This study's objective was to understand the role of ADAM10 on DCs in the development of allergic and anaphylactic responses. METHODS: In this study, we used mouse models of allergic airway inflammation (house dust mice and Alternaria alternata) and OVA-induced models of active anaphylaxis to determine the DC-specific function of ADAM10 and Notch signaling. To examine TH 1 and TH 17 immunity infection with Anaplasma phagocytophilum and Citrobacter rodentium respectively, were used. RESULTS: Mice, which have ADAM10 deleted from DCs, have dramatic reductions in IgE production and do not develop significant TH 2 immune responses. Further, ADAM10DC-/- mice are resistant to IgE-mediated anaphylaxis. This response is selective for TH 2 immunity as TH 1 and TH 17 immunity is largely unaffected. Notch1, a known ADAM10 substrate, when knocked out of DCs (Notch1DC-/- ) demonstrated a similar reduction in anaphylaxis and IgE. Without ADAM10 and Notch1 signaling, DCs were unable to make cytokines that stimulate TH 2 cells and cytokines. Anaphylaxis and allergic lung inflammation were restored in ADAM10DC-/- with the overexpression of the Notch1-intracellular domain, confirming the role of Notch signaling. CONCLUSIONS: Targeting ADAM10 and Notch1 on DCs represent a novel strategy for modulating TH 2 immune responses and IgE production.
BACKGROUND:Allergy and allergic asthma are significant health burdens in developed countries and are increasing in prevalence. Dendritic cells (DCs) initiate immune responses to common aeroallergens, and ADAM10 has been demonstrated to be important for the development of adaptive responses. This study's objective was to understand the role of ADAM10 on DCs in the development of allergic and anaphylactic responses. METHODS: In this study, we used mouse models of allergic airway inflammation (house dust mice and Alternaria alternata) and OVA-induced models of active anaphylaxis to determine the DC-specific function of ADAM10 and Notch signaling. To examine TH 1 and TH 17 immunity infection with Anaplasma phagocytophilum and Citrobacter rodentium respectively, were used. RESULTS:Mice, which have ADAM10 deleted from DCs, have dramatic reductions in IgE production and do not develop significant TH 2 immune responses. Further, ADAM10DC-/- mice are resistant to IgE-mediated anaphylaxis. This response is selective for TH 2 immunity as TH 1 and TH 17 immunity is largely unaffected. Notch1, a known ADAM10 substrate, when knocked out of DCs (Notch1DC-/- ) demonstrated a similar reduction in anaphylaxis and IgE. Without ADAM10 and Notch1 signaling, DCs were unable to make cytokines that stimulate TH 2 cells and cytokines. Anaphylaxis and allergic lung inflammation were restored in ADAM10DC-/- with the overexpression of the Notch1-intracellular domain, confirming the role of Notch signaling. CONCLUSIONS: Targeting ADAM10 and Notch1 on DCs represent a novel strategy for modulating TH 2 immune responses and IgE production.
Authors: J A Hirota; A Budelsky; D Smith; B Lipsky; R Ellis; Y-Y Xiang; W-Y Lu; M D Inman Journal: Clin Exp Allergy Date: 2010-03-12 Impact factor: 5.018
Authors: Andrea C Valladao; Charles W Frevert; Lisa K Koch; Daniel J Campbell; Steven F Ziegler Journal: J Immunol Date: 2016-11-04 Impact factor: 5.422
Authors: Dieter Hartmann; Bart de Strooper; Lutgarde Serneels; Katleen Craessaerts; An Herreman; Wim Annaert; Lieve Umans; Torben Lübke; Anna Lena Illert; Kurt von Figura; Paul Saftig Journal: Hum Mol Genet Date: 2002-10-01 Impact factor: 6.150
Authors: Stephen J Jenkins; Georgia Perona-Wright; Alan G F Worsley; Naoto Ishii; Andrew S MacDonald Journal: J Immunol Date: 2007-09-15 Impact factor: 5.422
Authors: Ansuman T Satpathy; Carlos G Briseño; Jacob S Lee; Dennis Ng; Nicholas A Manieri; Wumesh Kc; Xiaodi Wu; Stephanie R Thomas; Wan-Ling Lee; Mustafa Turkoz; Keely G McDonald; Matthew M Meredith; Christina Song; Cynthia J Guidos; Rodney D Newberry; Wenjun Ouyang; Theresa L Murphy; Thaddeus S Stappenbeck; Jennifer L Gommerman; Michel C Nussenzweig; Marco Colonna; Raphael Kopan; Kenneth M Murphy Journal: Nat Immunol Date: 2013-08-04 Impact factor: 25.606
Authors: Matthias Vanderkerken; Bastiaan Maes; Lana Vandersarren; Wendy Toussaint; Kim Deswarte; Manon Vanheerswynghels; Philippe Pouliot; Liesbet Martens; Sofie Van Gassen; Connie M Arthur; Margaret E Kirkling; Boris Reizis; Daniel Conrad; Sean Stowell; Hamida Hammad; Bart N Lambrecht Journal: Proc Natl Acad Sci U S A Date: 2020-11-19 Impact factor: 11.205
Authors: Courtney F Pierce; Vienna R Brown; Steven C Olsen; Paola Boggiatto; Kerri Pedersen; Ryan S Miller; Scott E Speidel; Timothy J Smyser Journal: Front Vet Sci Date: 2020-11-25
Authors: Alexandra L Matthews; Chek Ziu Koo; Justyna Szyroka; Neale Harrison; Aditi Kanhere; Michael G Tomlinson Journal: Front Immunol Date: 2018-07-02 Impact factor: 7.561
Authors: Qian Dong; Joan K Lunney; Kyu-Sang Lim; Yet Nguyen; Andrew S Hess; Hamid Beiki; Raymond R R Rowland; Kristen Walker; James M Reecy; Christopher K Tuggle; Jack C M Dekkers Journal: BMC Vet Res Date: 2021-02-22 Impact factor: 2.741